Clinical Trial Update: Intended Use Study of the BD SurePath Plus™ Pap

View source ↗

Summary

Clinical trial update for the intended use study of the BD SurePath Plus Pap; the study is terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Neoplasms By Histologic Type
• Neoplasms Glandular and Epithelial
• Neoplasms Squamous Cell
• Papilloma
• Uterine Cervical Cancer
• Uterine Cervical Neoplasms

Drugs mentioned

• BD SurePath Plus Pap

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Uterine Cervical Neoplasms, Uterine Cervical Cancer | Status: TERMINATED | Results posted: 2021-05-05